Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000908662-10-000003
Filing Date
2010-01-05
Accepted
2010-01-05 16:50:11
Documents
1
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3297
  Complete submission text file 0000908662-10-000003.txt   5072
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0101
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address
MCNAMARA PAMELA W (Reporting) CIK: 0001239717 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 10507620